C-Fos antibody
| Antigen | C-Fos |
| Clonality | Polyclonal |
| Host | |
| Reactivity |
Alternatives Human, Mouse (Murine), Rat (Rattus) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Western Blotting (WB) |
![]() |
3 references available |
| Catalog no. | ABIN965712 |
| Quantity | 100myg |
| Price | 316.25 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 5 to 7 Business Days |
Additional Information
| Immunogen | A synthetic peptide corresponding to a sequence at the middle region of human C-FOS, identical to the related rat and mouse sequence. |
| Reconstitution | 0.2ml of distilled water will yield a concentration of 500µg/ml. |
| Description | The human oncogene c-fos is cellular homolog of the transforming gene of Finkel-Biskis-Jinkins (FBJ) murine osteosarcoma virus which was mapped to a single human chromosome.1 c-Fos is encoded by the FOS gene. FOS was the first transcription factor identified that has a critical function in regulating the development of cells destined to form and maintain the skeleton. FOS is also a major component of the activator protein-1 (AP-1) transcription factor complex, which includes members of the JUN family. c-fos is a major nuclear target for signal transduction pathways involved in the regulation of cell growth, differentiation, and transformation.2 Using transgenic and knockout mice, Grigoriadis et al. (1995) established a unique role for the proto-oncogene and nuclear transcription factor, Fos, in regulating the differentiation and activity of specific bone cell populations, both during normal development and in bone disease. 3 |
Application Details
| Buffer | Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4 |
| Preservative | 0.05mg Thiomersal, 0.05mg NaN3. |
| Storage | At -20°C for one year. After reconstitution, at 4°C for one month. |
| Restrictions | For Research Use only |
Publications
| Product |
Barker, Rabin, Watson et al.: "Human c-fos oncogene mapped within chromosomal region 14q21----q31." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 81, Issue 18, pp. 5826-30, 1984 (PubMed).
Saez, Rutberg, Mueller et al.: "c-fos is required for malignant progression of skin tumors." in: Cell, Vol. 82, Issue 5, pp. 721-32, 1995 (PubMed). Grigoriadis, Wang, Wagner: "Fos and bone cell development: lessons from a nuclear oncogene." in: Trends in genetics : TIG, Vol. 11, Issue 11, pp. 436-41, 1996 (PubMed). |
Alternatives
Alternatives for antigen "C-Fos", type "Antibodies"




Alternatives